Terms and Data
Intraday Chart Close
Call Level6.2 Spot to Call Level3.1 / 33.05 %
Strike5.9 Difference between
Call & Strike Price0.30
Effective Gearing(X)*2.8 Delta*1
Entitlement Ratio10 Approximate Change for 1 Tick
Price Change of CBBC (Sensitivity)*0.05HKD
CBBCTypeR Outstanding Quantity
(M) / %0.0/ 0.0%
Maturity
(Y-M-D)2027-11-12
Premium (%)-1.2
Listing 2025-11-10
Today 2026-03-11
Last Trading 2027-11-11
Maturity 2027-11-12
Last Trade Date (YYYY-MM-DD)2027-11-11 Break-Even (HKD)9.15
Board Lot (Shares)2,000  
Listing 2025-11-10
Today 2026-03-11
Last Trading 2027-11-11
Maturity 2027-11-12
*Effective Gearing, Delta, and Sensitivity are derived from J.P. Morgan’s proprietary pricing model. These parameters reflect the relationship between the price of the underlying asset and the theoretical price changes of the CBBC. Investors should note that these figures are for reference only and may fluctuate with changes in the underlying asset price and the remaining time to maturity of the CBBC. In addition to the performance of the underlying asset, the CBBC price may also be affected by other market factors. For details, please refer to our educational articles and the listing documents.
Related Document
Listing Document Download Additional DocumentDownload Announcement-
Underlying
9.26
Change (%)
+0.110 (+1.2%)
  • High 9.48
  • Low 9.19
  • Turnover 720.7 (M)
CBBC Money Flow of Underlying More
Last Day
-0.05(M)
-(M)
5 Days
0.19(M)
-0.13(M)
  • Money In-Flow
  • Money Out-Flow
Last Updated Time : 2026-03-10 16:35   |   (Delayed*) - Minimum 15 mins delayed
  • 2025-12-19 【焦點板塊】藥股上日造好 石藥集團升逾6% 為表現最好藍籌 石藥購 23106/沽17854
  • 2025-10-10 【醫藥板塊】石藥指自主研發一款注射液獲美國食品藥物管理局(FDA)批准 可在美國開展臨床試驗 石藥購19427/沽17854
  • 2025-09-11 【行業消息】市場關注政策風險 生物醫藥股普遍下挫 石藥購19427 中藥購 18552/購 19129 信藥購19131 百濟購19925